[
  {
    "title": "泰恩康：全资子公司收到孟鲁司特钠颗粒药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2022/11/14165837137315.shtml",
    "datetime": "2022-11-14 16:58:00",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：第三季度净利4960.14万元，同比增长123.79%",
    "href": "http://stock.jrj.com.cn/2022/10/28090437092513.shtml",
    "datetime": "2022-10-28 09:04:06",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：278.9785万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/09/27171537025177.shtml",
    "datetime": "2022-09-27 17:15:54",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)半年度净利润7755.71万元 同比增长35.58%",
    "href": "http://stock.jrj.com.cn/2022/08/29214336949355.shtml",
    "datetime": "2022-08-29 21:43:33",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：拟出资1.01亿元参设广州赛富泰恩康医疗产业基金",
    "href": "http://stock.jrj.com.cn/2022/07/20200036829704.shtml",
    "datetime": "2022-07-20 20:00:57",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：他达拉非片拟中选江苏集采续签",
    "href": "http://stock.jrj.com.cn/2022/07/04175336780580.shtml",
    "datetime": "2022-07-04 17:53:24",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康6月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/23180736753902.shtml",
    "datetime": "2022-06-23 18:07:25",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：他达拉非片(商标名：爱廷威)获批上市",
    "href": "http://stock.jrj.com.cn/2022/06/22172936750054.shtml",
    "datetime": "2022-06-22 17:29:27",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康6月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/17180236738705.shtml",
    "datetime": "2022-06-17 18:02:50",
    "code": "301263"
  },
  {
    "title": "泰恩康聘任张震、孙涛为公司副总经理 2021年公司净利1.2亿",
    "href": "http://stock.jrj.com.cn/2022/06/14223136729300.shtml",
    "datetime": "2022-06-14 22:31:35",
    "code": "301263"
  },
  {
    "title": "泰恩康2022年第一季度净利5387.56万同比增长210.8% 自产产品爱廷玖销售增加",
    "href": "http://stock.jrj.com.cn/2022/05/04115036554812.shtml",
    "datetime": "2022-05-04 11:50:59",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)一季度净利润5387.56万元 同比增长210.8%",
    "href": "http://stock.jrj.com.cn/2022/04/26205436478506.shtml",
    "datetime": "2022-04-26 20:54:22",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)2021年度净利润降25.34%至1.2亿元 拟10派3.5元",
    "href": "http://stock.jrj.com.cn/2022/04/26205236478508.shtml",
    "datetime": "2022-04-26 20:52:24",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康4月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/13180336325377.shtml",
    "datetime": "2022-04-13 18:03:58",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康4月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/12180336316111.shtml",
    "datetime": "2022-04-12 18:03:45",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康4月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/08180336273287.shtml",
    "datetime": "2022-04-08 18:03:52",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康4月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/07180236268653.shtml",
    "datetime": "2022-04-07 18:02:52",
    "code": "301263"
  },
  {
    "title": "【龙虎榜】泰恩康3月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/29180536151065.shtml",
    "datetime": "2022-03-29 18:05:33",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)将3月29日在深交所上市",
    "href": "http://stock.jrj.com.cn/2022/03/27173435593077.shtml",
    "datetime": "2022-03-27 17:34:45",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)披露上市发行结果：遭弃购9.1694万股 由主承销商包销",
    "href": "http://stock.jrj.com.cn/2022/03/23203234873406.shtml",
    "datetime": "2022-03-23 20:32:02",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)披露中签结果：中签号码共有5.16万个",
    "href": "http://stock.jrj.com.cn/2022/03/21204434857485.shtml",
    "datetime": "2022-03-21 20:44:08",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：回拨后网上定价发行的中签率为0.0214354958%",
    "href": "http://stock.jrj.com.cn/2022/03/20172634852209.shtml",
    "datetime": "2022-03-20 17:26:19",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)IPO定价为19.93元/股 3月18日申购",
    "href": "http://stock.jrj.com.cn/2022/03/16205534835917.shtml",
    "datetime": "2022-03-16 20:55:11",
    "code": "301263"
  },
  {
    "title": "泰恩康(301263.SZ)：网上路演时间为3月17日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2022/03/15205834830945.shtml",
    "datetime": "2022-03-15 20:58:19",
    "code": "301263"
  },
  {
    "title": "泰恩康2021年净利1.2亿同比下滑25.34% 本期口罩收入和利润降幅较大",
    "href": "http://stock.jrj.com.cn/2022/02/09191034314351.shtml",
    "datetime": "2022-02-09 19:10:48",
    "code": "301263"
  },
  {
    "title": "卷土重来的泰恩康，这一次能否成功？",
    "href": "http://stock.jrj.com.cn/2021/12/09083133988391.shtml",
    "datetime": "2021-12-09 08:31:25",
    "code": "301263"
  },
  {
    "title": "泰恩康IPO：主业收入下降 口罩销售难支撑业绩增长",
    "href": "http://stock.jrj.com.cn/2021/12/06091833972561.shtml",
    "datetime": "2021-12-06 09:18:00",
    "code": "301263"
  },
  {
    "title": "泰恩康IPO过会：转型医药制造但自主研发能力弱 高溢价收购涉嫌利益输送",
    "href": "http://stock.jrj.com.cn/2021/10/27103233760814.shtml",
    "datetime": "2021-10-27 10:32:00",
    "code": "301263"
  },
  {
    "title": "泰恩康IPO过会：转型医药制造但自主研发能力弱 高溢价收购涉嫌利益输送",
    "href": "http://stock.jrj.com.cn/2021/10/27103233835290.shtml",
    "datetime": "2021-10-27 10:32:00",
    "code": "301263"
  },
  {
    "title": "泰恩康业绩大幅波动口罩贡献34%营收 销售费过亿核心产品代理权稳定性存疑",
    "href": "http://stock.jrj.com.cn/2021/09/17071333449112.shtml",
    "datetime": "2021-09-17 07:13:52",
    "code": "301263"
  },
  {
    "title": "泰恩康过会：今年IPO过关第307家 国泰君安过15.5单",
    "href": "http://stock.jrj.com.cn/2021/09/16095433443974.shtml",
    "datetime": "2021-09-16 09:54:00",
    "code": "301263"
  },
  {
    "title": "奥扬科技、泰恩康、三博脑科将于9月15日创业板上会",
    "href": "http://stock.jrj.com.cn/2021/09/09172633410198.shtml",
    "datetime": "2021-09-09 17:26:15",
    "code": "301263"
  },
  {
    "title": "奥扬科技、泰恩康、三博脑科9月15日创业板首发上会",
    "href": "http://stock.jrj.com.cn/2021/09/08195833405691.shtml",
    "datetime": "2021-09-08 19:58:00",
    "code": "301263"
  },
  {
    "title": "泰恩康2021年半年度净利5720.44万元 同比净利减少37.13%",
    "href": "http://stock.jrj.com.cn/2021/08/31161833361521.shtml",
    "datetime": "2021-08-31 16:18:00",
    "code": "301263"
  },
  {
    "title": "泰恩康2021年上半年净利5720.44万下滑37.13% 销售费用增加",
    "href": "http://stock.jrj.com.cn/2021/08/16182733261717.shtml",
    "datetime": "2021-08-16 18:27:53",
    "code": "301263"
  },
  {
    "title": "泰恩康2020年净利1.6亿元增长192.92% 口罩销售大增",
    "href": "http://stock.jrj.com.cn/2021/03/29213532243428.shtml",
    "datetime": "2021-03-29 21:35:24",
    "code": "301263"
  },
  {
    "title": "卖口罩撑起收入门面？ 泰恩康二闯创业板遭问询",
    "href": "http://stock.jrj.com.cn/2021/02/23004232008366.shtml",
    "datetime": "2021-02-23 00:42:13",
    "code": "301263"
  },
  {
    "title": "毛利率较高且持续上升是否合理？泰恩康回复创业板IPO首轮问询",
    "href": "http://stock.jrj.com.cn/2021/02/22141832005700.shtml",
    "datetime": "2021-02-22 14:18:35",
    "code": "301263"
  },
  {
    "title": "泰恩康创业板IPO获受理：2020年上半年利润达0.84亿元",
    "href": "http://stock.jrj.com.cn/2020/11/11140831259003.shtml",
    "datetime": "2020-11-11 14:08:35",
    "code": "301263"
  },
  {
    "title": "泰恩康2019年净利5490.42万下滑26.25% 推广效应未同期增加销售收入",
    "href": "http://stock.jrj.com.cn/2020/04/21180029339731.shtml",
    "datetime": "2020-04-21 18:00:31",
    "code": "301263"
  },
  {
    "title": "泰恩康拟以发行股份方式购买控股子公司少数股东权益 去年营收近5亿",
    "href": "http://stock.jrj.com.cn/2020/04/21152729338726.shtml",
    "datetime": "2020-04-21 15:27:18",
    "code": "301263"
  },
  {
    "title": "泰恩康任命李挺为公司副总经理 不持有公司股份",
    "href": "http://stock.jrj.com.cn/2020/01/20224328708477.shtml",
    "datetime": "2020-01-20 22:43:53",
    "code": "301263"
  },
  {
    "title": "泰恩康IPO被否 收购致大额商誉遭关注",
    "href": "http://stock.jrj.com.cn/2019/08/23043228019894.shtml",
    "datetime": "2019-08-23 04:32:42",
    "code": "301263"
  },
  {
    "title": "8月22日IPO快报：仙乐健康过会 新三板公司泰恩康被否",
    "href": "http://stock.jrj.com.cn/2019/08/22165728017432.shtml",
    "datetime": "2019-08-22 16:57:53",
    "code": "301263"
  },
  {
    "title": "泰恩康闯关创业板 业内质疑一箩筐",
    "href": "http://stock.jrj.com.cn/2019/08/22004128013382.shtml",
    "datetime": "2019-08-22 00:41:18",
    "code": "301263"
  },
  {
    "title": "泰恩康IPO或面临灵魂拷问：挂牌新三板期间涉嫌隐瞒员工总数和连续3年欠缴社保",
    "href": "http://stock.jrj.com.cn/2019/08/21135528010293.shtml",
    "datetime": "2019-08-21 13:55:37",
    "code": "301263"
  },
  {
    "title": "泰恩康2018年营收微涨15%：七成来自代理销售 闯关IPO存风险",
    "href": "http://stock.jrj.com.cn/2019/02/27183127098220.shtml",
    "datetime": "2019-02-27 18:31:53",
    "code": "301263"
  },
  {
    "title": "泰恩康预计2018年营收5.19亿 归母净利润7547.08万",
    "href": "http://stock.jrj.com.cn/2019/02/26190827093334.shtml",
    "datetime": "2019-02-26 19:08:00",
    "code": "301263"
  },
  {
    "title": "泰恩康2018年第三季度营收1.25亿 净利1903万",
    "href": "http://stock.jrj.com.cn/2018/10/30200325281210.shtml",
    "datetime": "2018-10-30 20:03:00",
    "code": "301263"
  },
  {
    "title": "泰恩康2018上半年营收2.44亿元 净利3277万元",
    "href": "http://stock.jrj.com.cn/2018/09/18144725107750.shtml",
    "datetime": "2018-09-18 14:47:00",
    "code": "301263"
  },
  {
    "title": "泰恩康2018年第一季度营收过亿 净利1331万",
    "href": "http://stock.jrj.com.cn/2018/04/27172224466543.shtml",
    "datetime": "2018-04-27 17:22:00",
    "code": "301263"
  },
  {
    "title": "【红刊财经】泰恩康营收、采购数据异常 未来盈利点尚待解决",
    "href": "http://stock.jrj.com.cn/2018/04/14101628697610.shtml",
    "datetime": "2018-04-14 10:16:55",
    "code": "301263"
  },
  {
    "title": "泰恩康与上海凯茂签订抗肿瘤药物产权转让合同",
    "href": "http://stock.jrj.com.cn/2018/04/09162224363128.shtml",
    "datetime": "2018-04-09 16:22:00",
    "code": "301263"
  },
  {
    "title": "拟IPO企业泰恩康2017年净利5515万元 同比翻番",
    "href": "http://stock.jrj.com.cn/2018/02/28192124171199.shtml",
    "datetime": "2018-02-28 19:21:00",
    "code": "301263"
  }
]